Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Heron Therapeutics Inc., 3 years.
Heron Therapeutics Inc.
Director · Chief Executive Officer
Connect Biopharma Holdings Limited
Director · Chief Executive Officer
Chief executive roles
Heron Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Connect Biopharma Holdings Limited
· Chief Executive Officer
Since March 2026
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kiniksa Pharmaceuticals International plc June 3, 202597.6%
-
Kiniksa Pharmaceuticals International plc June 6, 202397.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Kiniksa Pharmaceuticals International plc | Gift | −2,600 | — | — |
| May 29, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,799 | — | — |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +13,099 | $14.33 | $187,709 |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −13,099 | $50.10 | $656,260 |
| Apr 6, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +6,901 | $14.33 | $98,891 |
| Apr 6, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −6,901 | $50.00 | $345,050 |
| Feb 12, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,690 | $15.47 | $41,614 |
| Feb 12, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −2,690 | $45.00 | $121,050 |
| Feb 10, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +110 | $15.47 | $1,702 |
| Feb 10, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −110 | $45.00 | $4,950 |
| Feb 4, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,602 | $15.47 | $40,253 |
| Feb 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −2,602 | $45.02 | $117,142 |
| Feb 3, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +12,528 | $15.47 | $193,808 |
| Feb 3, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −12,528 | $45.27 | $567,143 |
| Feb 2, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +830 | $15.47 | $12,840 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.